Publications by authors named "M Abernathy"

Claim this Profile
L
Legacy hERG study data in contemporary integrated risk assessments - mitigating the risk of protocol and positive control article differences.
Richard W Daniels, James W Kramer, Matthew M Abernathy, Derek D Best, Jessica C Brimecombe

J Pharmacol Toxicol Methods· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telemetry in toxicology studies - A comparison of data across species, technologies and time.
Derek D Best, Matthew M Abernathy, Derek J Leishman

J Pharmacol Toxicol Methods· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs.
Matthew M Abernathy, Derek D Best, Derek J Leishman

J Pharmacol Toxicol Methods· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern.
Adonis A Rubio, Viren A Baharani, Bernadeta Dadonaite, Megan Parada, Morgan E Abernathy

Sci Transl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstrating the statistical and pharmacological sensitivity of nonclinical QTc analysis using a dofetilide dose-response in nonhuman primates.
Derek J Leishman, David L Holdsworth, Derek D Best, Matthew M Abernathy, Brian M Roche

J Pharmacol Toxicol Methods· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis